drugset / Trial / NCT03144882
Evaluation of Curcumin's Effect on Inflammation in Hemodialysis Patients
RandomizedParallel-groupDouble-blindPrevention
Summary
Programmed ingestion of turmeric has no adverse effects and reduces plasma level of hs-CRP, IL-6 and TNF-α accompanying with increases albumin levels in hemodialysis patients. Turmeric can be considered as an effective anti-inflammatory supplement in hemodialysis patients.
Timeline
- Start
- 2015-02-02
- Primary completion
- 2016-02-02
- Completion
- 2017-02-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Curcumin | Small molecule | — | — |